LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006231.4:c.2964G>T
POLE
· NP_006222.2:p.(Ser988=)
· NM_006231.4
GRCh37: chr12:133237651 C>A
·
GRCh38: chr12:132661065 C>A
Gene:
POLE
Transcript:
NM_006231.4
Final call
VUS
PM2 supporting
BP7 supporting
Variant details
Gene
POLE
Transcript
NM_006231.4
Protein
NP_006222.2:p.(Ser988=)
gnomAD AF
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada — no carriers in large control populations.
2
BP7 (Supporting): synonymous p.Ser988= with SpliceAI max delta 0.01, predicting no splice impact.
3
Overall: VUS — the conflicting PM2 and BP7 supporting evidence satisfies no enumerated Pathogenic, Likely Pathogenic, Benign, or Likely Benign combination.
Final determination:
The only met criteria are PM2 (supporting, pathogenic direction) and BP7 (supporting, benign direction), which conflict, and no enumerated ACMG/AMP 2015 Pathogenic/Likely Pathogenic/Benign/Likely Benign combination is satisfied, so the framework combination rule classifies this as Uncertain Significance (VUS).
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.2964G>T is synonymous (p.Ser988=) with no predicted splice impact, so it is not a null variant (SpliceAI max delta 0.01). |
pvs1_variant_assessment
pvs1_generic_framework
pvs1_gene_context
spliceai
generic_acmg_combination_rules
final_classification_framework
|
| PS1 | N/A | Not applicable: the variant is synonymous (p.Ser988=), so no amino acid change exists to match a known pathogenic change. |
pvs1_variant_assessment
pm5_candidates
vcep_path_250_323
PMID:25394175
|
| PS2 | Not assessed | Not assessed: no de novo occurrence with confirmed parental testing is documented in ClinVar or the literature. |
clinvar
PMID:25394175
generic_acmg_combination_rules
final_classification_framework
|
| PS3 | Not assessed | Not assessed: no functional assay of this variant exists; the only related data is an in silico SpliceAI prediction (max delta 0.01), not a functional study. |
PMID:25394175
vcep_path_250_323
spliceai
generic_acmg_combination_rules
|
| PS4 | Not met | Not met: the gene-specific rule applies only to recurrent missense variants (none at residue 988), and no case-control study exists for this variant. |
final_classification_framework
vcep_path_250_323_s002
clinvar
PMID:25394175
|
| PM1 | N/A | Not applicable: p.Ser988= is synonymous and lies outside the exonuclease domain (residues ~268-471) where all framework hotspots reside. |
vcep_path_250_323
vcep_path_250_323_s002
pvs1_variant_assessment
PMID:25394175
|
| PM2 | Met | Met (supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada, satisfying the 'absent in controls' population criterion. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| PM3 | Not assessed | Not assessed: no proband genotype or phase data exist to evaluate a trans configuration with a pathogenic variant. |
clinvar
pm5_candidates
generic_acmg_combination_rules
final_classification_framework
PMID:25394175
|
| PM4 | N/A | Not applicable: a synonymous single-nucleotide substitution changes no amino acid and introduces no in-frame indel. |
generic_acmg_combination_rules
final_classification_framework
|
| PM5 | N/A | Not applicable: the variant is synonymous (p.Ser988=), so there is no missense change to compare against a known pathogenic change. |
pm5_candidates
pvs1_variant_assessment
vcep_path_250_323
PMID:25394175
|
| PM6 | Not assessed | Not assessed: no de novo occurrence, with or without parentage confirmation, is documented for this variant. |
clinvar
PMID:25394175
generic_acmg_combination_rules
final_classification_framework
|
| PP1 | Not assessed | Not assessed: no segregation study or family testing data exists — zero informative meioses are documented. |
clinvar
PMID:25394175
generic_acmg_combination_rules
final_classification_framework
|
| PP2 | N/A | Not applicable: PP2 applies to missense variants, and this variant is synonymous (p.Ser988=). |
pvs1_variant_assessment
vcep_path_250_323
PMID:25394175
|
| PP3 | Not met | Not met: SpliceAI predicts no splice impact (max delta 0.01), the only predictor available, so no computational evidence supports a deleterious effect. |
spliceai
vcep_path_250_323_s003
vcep_path_250_323_s004
final_classification_framework
generic_acmg_combination_rules
pvs1_variant_assessment
|
| PP4 | Not assessed | Not assessed: no proband phenotype or family-history data for a carrier of this variant is available. |
|
| PP5 | Not met | Not met: no ClinVar expert-panel (3-star) pathogenic classification exists; the only submission is a 1-star laboratory 'Likely benign'. |
clinvar
|
| BA1 | Not met | Not met: the variant is absent (frequency 0) from gnomAD v2.1, v4.1, and gnomAD-Canada, so no population threshold is exceeded. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| BS1 | Not met | Not met: observed frequency is 0 in all three population databases, the opposite of a frequency greater than expected. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| BS2 | Not met | Not met: no healthy adult carriers or homozygotes are observed; the variant is absent from all three population databases. |
gnomad_v2
gnomad_v4
gnomad_canada
generic_acmg_combination_rules
|
| BS3 | Not assessed | Not assessed: no functional studies of this variant exist; in silico and population data cannot substitute for them. |
spliceai
clinvar
oncokb
PMID:25394175
vcep_path_250_323
generic_acmg_combination_rules
|
| BS4 | Not assessed | Not assessed: no affected family member has been tested and reported as not carrying the variant. |
clinvar
PMID:25394175
generic_acmg_combination_rules
final_classification_framework
|
| BP1 | N/A | Not applicable: BP1 applies to missense variants, and this variant is synonymous (p.Ser988=). |
pvs1_variant_assessment
vcep_path_250_323
pvs1_gene_context
PMID:25394175
|
| BP2 | Not assessed | Not assessed: no genotype data exists to establish a trans or cis configuration with a pathogenic variant. |
clinvar
pm5_candidates
generic_acmg_combination_rules
final_classification_framework
PMID:25394175
|
| BP3 | N/A | Not applicable: the variant is a single-nucleotide substitution, not an in-frame indel in a repeat region. |
generic_acmg_combination_rules
final_classification_framework
|
| BP4 | Not met | Not met: the only 'no impact' prediction (SpliceAI max delta 0.01) is already counted under BP7; no independent benign computational line exists. |
spliceai
vcep_path_250_323_s003
vcep_path_250_323_s004
final_classification_framework
generic_acmg_combination_rules
|
| BP5 | Not assessed | Not assessed: no reported carrier with an alternate molecular basis exists, so an alternate diagnosis can be neither established nor excluded. |
|
| BP6 | Not met | Not met: the 'Likely benign' label is a 1-star laboratory submission, not an expert-panel classification, so BP6 does not apply. |
clinvar
|
| BP7 | Met | Met (supporting): synonymous p.Ser988= with SpliceAI max delta 0.01, far below the 0.2 impact threshold, predicting no splice effect. |
spliceai
pvs1_variant_assessment
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.